Skip to search formSkip to main contentSkip to account menu

BMS 284756

Known as: BMS-284756, BMS284756 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2003
Highly Cited
2003
ABSTRACT The new quinolone garenoxacin (BMS-284756), which lacks a C-6 fluorine, was examined for its ability to block the growth… 
2002
2002
ABSTRACT The in vitro activities of BMS-284756 (a novel des-fluoroquinolone), levofloxacin, moxifloxacin, and clarithromycin were… 
2002
2002
ABSTRACT The in vitro antibacterial activity of BMS-284756 was compared to those of ciprofloxacin, gatifloxacin, moxifloxacin… 
2002
2002
The study was initiated to determine the in vitro activity and MIC/disk test comparisons of BMS284756, a new des-fluoro(6… 
Highly Cited
2001
Highly Cited
2001
Sir, BMS-284756 (BMS; T-3811ME) is a novel compound, lacking the 6-position fluorine typical of existing fluoroquinolones, which… 
2001
2001
ABSTRACT T-3811, the free base of T-3811ME (BMS-284756), a new des-F(6)-quinolone, showed a potent in vitro activity (MIC at… 
2001
2001
ABSTRACT BMS-284756 is a novel des-fluoro(6) quinolone with a broad antimicrobial activity, including Streptococcus pneumoniae… 
2001
2001
ABSTRACT BMS-284756, a novel des-fluoro(6)-quinolone, was used to select for in vitro mutants of Staphylococcus aureusISP794… 
2001
2001
The activity of BMS-284756 was studied against extracellular Legionella spp. and intracellular Legionella pneumophila, and for… 
2001
2001
Analogues of BMS-284756, a novel des-F(6)-quinolone, were synthesized and evaluated in order to determine the effects of…